Deb Hart
Vice President, Investor Relations
Replay available
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bernd Brust
Chief Executive Officer
Rajesh Asarpota
Chief Financial Officer
Kurt Oreshack
Executive Vice President and General Counsel
Matt Stanton
Analyst, Jefferies
Subbu Namdi
Analyst, Guggenheim
Matt Hewitt
Analyst, Craig-Hallum Capital Group
Jason Brough
Analyst, Deutsche Bank
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Maravai Lifesciences Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.165 -- 00:00:06.266 Hello and welcome everyone joining today's Mara Vi LifeSciences Q2 2026 00:00:06.266 -- 00:00:11.247 Results Earnings Call. At this time, all participants are in a listen-only mode. 00:00:11.247 -- 00:00:14.807 Later, you will have the opportunity to ask questions during the question and answer 00:00:14.807 -- 00:00:19.988 session. To register to ask a question at any time, please press star 1 on your telephone 00:00:19.988 -- 00:00:24.029 keypad. Please note this call is being recorded and we are standing by should you need 00:00:24.029 -- 00:00:25.729 any assistance. 00:00:25.729 -- 00:00:28.910 It is now my pleasure to turn the meeting over to Deb Hart. 00:00:28.910 -- 00:00:30.122 Please go ahead. 00:00:30.122 -- 00:00:34.944 Good afternoon, everyone. Thanks for joining us for our second quarter 2026 earnings 00:00:34.944 -- 00:00:41.305 call. The press release and slides accompanying today's call are available at investors.maravai.com. 00:00:41.846 -- 00:00:46.468 As you can see from the agenda on slide two, our CEO, Bernd Brust, will provide a business 00:00:46.468 -- 00:00:51.649 update, and our CFO, Rajesh Asarpota, will review our financial results. 00:00:51.649 -- 00:00:57.131 Dr. Chanfeng Zhao, our Chief Scientific Officer, and Kurt Oreshack, 00:00:57.131 -- 00:01:03.420 our Executive Vice President and General Counsel, will join us for the Q&A session. 00:01:03.420 -- 00:01:07.203 Management will make forward-looking statements and refer to GAAP and non-GAAP financial 00:01:07.203 -- 00:01:13.268 measures during today's call. Actual results could differ materially from expectations. 00:01:13.268 -- 00:01:16.650 We will undertake no obligation to update them. 00:01:16.650 -- 00:01:21.113 We refer you to slide three for d...